Physician profile
Nancy Wong
NPI 1619138310
$11,680.66
in general payments reported to CMS, 2019-2025
18 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 86% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.95 · 2020: $145 · 2021: $1,591 · 2022: $1,537 · 2023: $3,973 · 2024: $2,210 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,168 · Consulting Fee: $1,700 · Travel and Lodging: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,168.08 |
| Consulting Fee | $1,700.00 |
| Travel and Lodging | $504.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $9,040.66 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $1,296.02 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memoryshape Breast Implant |
| Musculoskeletal Transplant Foundation INC. | $341.47 | 2023-2024 | |
| Innovation Technologies INC | $246.23 | 2022 | |
| Sientra, INC. | $168.73 | 2022 | |
| Stryker Corporation | $138.37 | 2019-2024 | Spy-Phi System |
| Acera Surgical, INC. | $134.88 | 2023 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $87.40 | 2020-2021 | |
| Abbvie INC. | $48.19 | 2023-2024 | Alloderm |
| Allergan, INC. | $46.44 | 2020-2021 | |
| Motiva USA, LLC | $31.05 | 2024 | |
| Polynovo North America LLC | $24.07 | 2025 | Novosorb Btm |
| Endo Pharmaceuticals INC. | $16.47 | 2023 | Xiaflex |
| Integra Lifesciences Corporation | $15.53 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Becton, Dickinson and Company | $14.34 | 2024 | Phasix Mesh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $13.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $11.14 | 2019 | |
| Kls-Martin L.P. | $6.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.